AZD-4320

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAZD-4320
Drug Alias NameAZD-4320
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsApoptosis regulator Bcl-X inhibitorsApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-XApoptosis regulator Bcl-2
Therapy Area/IndicationsSmall Cell Lung CarcinomaHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A